| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 198 |
| 1 | IBUPROFEN | 197 |
| 2 | IBUPFROFEN | 195 |
| 3 | IBUPROFEN 200 MG | 195 |
| 4 | IBUPROFEN 200MG | 195 |
| 5 | IBUPROFEN CAPSULE | 195 |
| 6 | IBUPROFEN CAPSULES 200 MG | 195 |
| 7 | IBUPROFEN ORAL | 195 |
| 8 | IBUPROFEN TABLET, FILM COATED | 195 |
| 9 | IBUPROFEN TABLET, FILM-COATED | 195 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZILEUTON | 3 | 0.0046 |
| 1 | FLURBIPROFEN | 5 | 0.0033 |
| 2 | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | 1 | 0.0030 |
| 3 | AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE | 9 | 0.0022 |
| 4 | RESLIZUMAB | 1 | 0.0015 |
| 5 | KETOPROFEN | 17 | 0.0013 |
| 6 | IBUPFROFEN | 195 | 0.0010 |
| 7 | IBUPROFEN TABLETS USP, 200MG | 195 | 0.0010 |
| 8 | IBUPROFEN ORAL | 195 | 0.0010 |
| 9 | IBUPROFEN CAPSULES 200 MG | 195 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 392 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 202 |
| 2 | Corticosteroid [EPC] | 88 |
| 3 | Anti-IgE [EPC] | 11 |
| 4 | Histamine-1 Receptor Antagonist [EPC] | 11 |
| 5 | Proton Pump Inhibitor [EPC] | 10 |
| 6 | Interleukin-4 Receptor alpha Antagonist [EPC] | 8 |
| 7 | Expectorant [EPC] | 6 |
| 8 | Leukotriene Receptor Antagonist [EPC] | 6 |
| 9 | P2Y12 Platelet Inhibitor [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 5-Lipoxygenase Inhibitor [EPC] | 3 | 0.0046 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Antiseptic [EPC] | 2 | 0.0005 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 202 | 0.0004 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 392 | 0.0003 |
| 5 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 6 | Leukotriene Receptor Antagonist [EPC] | 6 | 0.0002 |
| 7 | Histamine-1 Receptor Antagonist [EPC] | 11 | 0.0001 |
| 8 | Anti-IgE [EPC] | 11 | 0.0001 |
| 9 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |